Humana Inc. (HUM) Upgraded to Hold at BidaskClub
BidaskClub upgraded shares of Humana Inc. (NYSE:HUM) from a sell rating to a hold rating in a report published on Wednesday.
HUM has been the subject of a number of other reports. Zacks Investment Research upgraded Humana from a hold rating to a buy rating and set a $256.00 price target for the company in a report on Monday, May 8th. Argus upgraded Humana from a hold rating to a buy rating and set a $260.00 price target for the company in a report on Friday, June 9th. Cantor Fitzgerald upped their price target on Humana from $190.00 to $200.00 and gave the stock a neutral rating in a report on Wednesday, April 26th. Citigroup Inc. started coverage on Humana in a report on Wednesday, June 28th. They set a buy rating and a $275.00 price target for the company. Finally, Credit Suisse Group reiterated an outperform rating and set a $250.00 price target (up from $245.00) on shares of Humana in a report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $244.35.
Humana (NYSE HUM) opened at 251.99 on Wednesday. Humana has a 12-month low of $163.50 and a 12-month high of $255.27. The firm’s 50-day moving average is $242.00 and its 200 day moving average is $225.90. The firm has a market cap of $36.42 billion, a PE ratio of 20.73 and a beta of 0.91.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period in the previous year, the company earned $2.30 earnings per share. Equities research analysts predict that Humana will post $11.55 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/24/humana-inc-hum-upgraded-to-hold-at-bidaskclub.html.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Tuesday, August 29th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.
In other Humana news, VP M Todoroff Christopher sold 22,935 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the transaction, the vice president now owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the transaction, the vice president now directly owns 8,150 shares in the company, valued at approximately $1,890,474. The disclosure for this sale can be found here. In the last three months, insiders sold 41,406 shares of company stock worth $10,355,086. Insiders own 0.80% of the company’s stock.
A number of institutional investors have recently bought and sold shares of HUM. WFG Advisors LP raised its position in Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after buying an additional 20 shares in the last quarter. Acrospire Investment Management LLC acquired a new position in Humana during the second quarter worth approximately $120,000. Independent Portfolio Consultants Inc. raised its position in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares in the last quarter. Finally, Fiduciary Trust Co. acquired a new position in Humana during the second quarter worth approximately $135,000. 99.13% of the stock is currently owned by institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.